Sign In
Buy MDRX
$4.80
-0.200 (-4.00%)
At Close: Jul 31, 2026
Reasons to Retain Allscripts (MDRX) Stock in Your Portfolio
01:50pm, Monday, 27'th Jun 2022
Investors continue to be optimistic about Allscripts (MDRX) owing to its strategic alliances.
Allscripts' (MDRX) Stock Falls 8.8% Post Q1 Earnings Miss
03:12pm, Tuesday, 10'th May 2022 Zacks Investment Research
Allscripts' (MDRX) robust Q1 results demonstrate strength in both segments.
Allscripts' (MDRX) Stock Falls 8.8% Post Q1 Earnings Miss
12:48pm, Tuesday, 10'th May 2022
Allscripts' (MDRX) robust Q1 results demonstrate strength in both segments.
Allscripts Healthcare Solutions, Inc. (MDRX) CEO Paul Black on Q1 2021 Results - Earnings Call Transcript
09:22am, Sunday, 08'th May 2022
Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX ) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants Jenny Gelinas - Vice President, Investor Relations Paul Black - Chief
Analyst Ratings for Allscripts Healthcare
08:32pm, Friday, 06'th May 2022 Benzinga
Allscripts Healthcare (NASDAQ:MDRX) has observed the following analyst ratings within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
1
1
2
0
0
AllScripts Healthcare (MDRX) Q1 Earnings and Revenues Lag Estimates
09:35pm, Thursday, 05'th May 2022 Zacks Investment Research
AllScripts (MDRX) delivered earnings and revenue surprises of -35% and 61.72%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
AllScripts Healthcare (MDRX) Q1 Earnings and Revenues Lag Estimates
06:48pm, Thursday, 05'th May 2022
AllScripts (MDRX) delivered earnings and revenue surprises of -35% and 61.72%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Here's Why You Should Retain Allscripts (MDRX) Stock For Now
03:55pm, Friday, 22'nd Apr 2022 Zacks Investment Research
Investors continue to be optimistic about Allscripts Healthcare Solutions (MDRX) owing to its strategic alliances.
Here's Why You Should Retain Allscripts (MDRX) Stock For Now
01:32pm, Friday, 22'nd Apr 2022
Investors continue to be optimistic about Allscripts Healthcare Solutions (MDRX) owing to its strategic alliances.
Reasons to Retain OPKO Health (OPK) Stock in Your Portfolio
05:05pm, Monday, 28'th Mar 2022 Zacks Investment Research
Investors continue to be optimistic about OPKO Health (OPK) owing to its potential in Rayaldee and regulatory approvals.
Masimo (MASI) Announces Favorable Study Results on SpHb
04:30pm, Monday, 28'th Mar 2022 Zacks Investment Research
Masimo's (MASI) SpHb is likely to enhance perioperative transfusion management and post-operative patient outcomes on pediatric patients.
Are You Looking for a Top Momentum Pick? Why AllScripts Healthcare (MDRX) is a Great Choice
04:00pm, Friday, 25'th Mar 2022 Zacks Investment Research
Does AllScripts Healthcare (MDRX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Reasons to Retain Intuitive Surgical (ISRG) Stock For Now
03:26pm, Friday, 25'th Mar 2022 Zacks Investment Research
Investors continue to be optimistic about Intuitive Surgical (ISRG) owing to its strength in robotics.
Is Lantheus Holdings (LNTH) Outperforming Other Medical Stocks This Year?
01:40pm, Friday, 25'th Mar 2022 Zacks Investment Research
Here is how Lantheus Holdings (LNTH) and AllScripts Healthcare (MDRX) have performed compared to their sector so far this year.
Here's Why You Should Retain BD (BDX) Stock in Your Portfolio
04:38pm, Thursday, 24'th Mar 2022 Zacks Investment Research
Investors continue to be optimistic about BD (BDX) owing to its slew of product launches and strategic deals.
